Dr. Jabbour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1407 S County Trl
Suite 430
East Greenwich, RI 02818Phone+1 401-886-7910Fax+1 401-886-7913- Is this information wrong?
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Critical Care Medicine, 2019 - 2020
- Roger Williams Medical CenterFellowship, Pulmonary Disease, 2017 - 2019
- Roger Williams Medical CenterResidency, Internal Medicine, 2014 - 2017
- Lebanese University School of MedicineClass of 2013
Certifications & Licensure
- MA State Medical License 2020 - 2025
- RI State Medical License 2014 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 4 citationsThe impact of different CPAP delivery approaches on nightly adherence and discontinuation rate in patients with obstructive sleep apnea.Michael Stanchina, Julie Lincoln, Susan Prenda, Molly Holt, Ingrid Leon, Walter Donat, William Corrao, Elias Jabbour, Seth Koenig, Atul Malhotra> ;Journal of Clinical Sleep Medicine. 2022 Aug 1
- 1 citationsSudden Cardiopulmonary Collapse in a Patient With Coronavirus Disease 2019.Elias Jabbour, Danish Malik, Ariel L. Shiloh> ;Chest. 2021 Feb 1
Lectures
- Final Results of Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Combined Ibrutinib and Venetoclax in Patients with Treatment-Naïve High-Risk Chronic Lymphocytic Leukemia (CLL)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Long Term Results of a Randomized Phase 2 Dose-Response Study of Guadecitabine, a Novel Subcutaneous (SC) Hypomethylating Agent (HMA), in 102 Patients with Intermediat...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Professional Memberships
- Member
Other Languages
- French, Arabic
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Kent HospitalWarwick, Rhode Island
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: